Description

BSE announces the addition of five newly listed companies to BSE IPO and BSE SME IPO indices, effective December 16-17, 2025.

Summary

BSE announces the addition of five newly listed companies to its indices. Corona Remedies Limited and Wakefit Innovations Limited will be added to the BSE IPO index effective December 17, 2025. Three SME companies - Riddhi Display Equipments Limited, K.V. Toys India Limited, and Prodocs Solutions Limited - will be added to the BSE SME IPO index effective December 16, 2025.

Key Points

  • Corona Remedies Limited (544644) and Wakefit Innovations Limited (544642) listed on BSE on December 15, 2025
  • Both companies will be added to BSE IPO index at market open on December 17, 2025
  • Riddhi Display Equipments Limited (544640), K.V. Toys India Limited (544641), and Prodocs Solutions Limited (544643) listed on BSE SME platform on December 15, 2025
  • All three SME companies will be added to BSE SME IPO index at market open on December 16, 2025
  • Changes included in end-of-day corporate action file (*.SDE)
  • Queries to be directed to bseindex@bseindia.com

Regulatory Changes

No regulatory changes. This is a routine index addition following new listings.

Compliance Requirements

No compliance requirements. This is an informational notice for market participants.

Important Dates

  • December 15, 2025: Listing date for all five companies on BSE
  • December 16, 2025: Riddhi Display Equipments Limited, K.V. Toys India Limited, and Prodocs Solutions Limited added to BSE SME IPO index (at market open)
  • December 17, 2025: Corona Remedies Limited and Wakefit Innovations Limited added to BSE IPO index (at market open)

Impact Assessment

Minimal market impact. This is a routine index maintenance action following new listings. Index funds tracking BSE IPO and BSE SME IPO indices will need to adjust their portfolios to include these newly added stocks. The staggered addition dates (December 16 for SME stocks and December 17 for mainboard stocks) allow for orderly index rebalancing.

Impact Justification

Routine index additions following new listings; informational update with no regulatory or compliance implications for existing market participants.